Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pharmather Holdings Ltd C.PHRM

Alternate Symbol(s):  PHRRF

psychedelics
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:PHRM)

PharmaTher's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

GlobeNewswire 4 days ago

PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine

GlobeNewswire April 18, 2024

PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine

GlobeNewswire April 16, 2024

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

GlobeNewswire April 2, 2024

PharmaTher's Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cepharanthine for Phase 1 Study in Australia

GlobeNewswire February 21, 2024

PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine

GlobeNewswire February 12, 2024

PharmaTher Provides Update for Expected FDA Approval of Ketamine

GlobeNewswire January 10, 2024

PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX(TM) (Ketamine)

GlobeNewswire September 27, 2023

PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX(TM) (Ketamine) to the FDA

GlobeNewswire September 6, 2023
View More News ››

Opinion & Analysis (CSE:PHRM)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:PHRM)

RE:High Impact...multi-bagger!!!!

Sorry my error...warrants are showing to be 16.8mm out at a exercise price of .80 cents...this could bring in potential cash funds of $13...
TheLandedEagles - 1 day ago

RE:FDA ?

Glloyd...respectfully, go look at last recent public releases.. will provide you the info you need !!!!!
TheLandedEagles - 6 days ago

FDA ?

I thought the FDA was supposed to be approved today the 29th. Any ideas why it hasn't been and there's no update or anything?
Glloyd - 6 days ago

RE:High Impact...multi-bagger!!!!

They are actually closer to 2 mil in the bank right now, so they really need to get this approval sooner than later.  Just as...
Itistoo - 6 days ago

High Impact...multi-bagger!!!!

Investors looking for Big Rewards with minimal risk at this late stage of a FDA imminent approval,...needs to have a locked-in share...
TheLandedEagles - 7 days ago

RE:RE:Why low-cost ketamine is still inaccessible to many...

For sure...thats how I see things here for PHRM. Short and long term, this company will be huge in valuation. Time will only tell of...
TheLandedEagles - 11 days ago
View more Bullboard ››

Star Diamond Corp

Star Diamond Corp

Star Diamond Corporation is a Canada-based company engaged in the acquisition, exploration and development of mineral ...
View More »